Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Temporal Trends and Disparities in Place of Death Among Patients With Lymphoma in the United States: A Nationwide CDC WONDER Analysis, 1999-2020

HL - 474

Temporal Trends and Disparities in Place of Death Among Patients With Lymphoma in the United States: A Nationwide CDC WONDER Analysis, 1999-2020

Juste Niba

Poster Presenter: Juste Niba

Thumbnail for Real-World Comparative Analysis of Treatment Discontinuation (TD) with Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) in First-Line (1L) Chronic Lymphocytic Leukemia (CLL)

CLL - 476

Real-World Comparative Analysis of Treatment Discontinuation (TD) with Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) in First-Line (1L) Chronic Lymphocytic Leukemia (CLL)

Derrick van Beuge

Poster Presenter: Derrick van Beuge

Previous 1...34 35 36 37 38 39 40...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

AML - 477

The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Beyond Hemolysis: Etiologic Diversity and Diagnostic Challenges in Cold Agglutinin Disorders With Implications for Targeted Therapy

IBCL - 478

Beyond Hemolysis: Etiologic Diversity and Diagnostic Challenges in Cold Agglutinin Disorders With Implications for Targeted Therapy

Krisztina Jeszenszky

Poster Presenter: Krisztina Jeszenszky

Thumbnail for Diagnostic and Therapeutic Access Gaps in Newly Diagnosed Multiple Myeloma: Real-World Evidence From a North Indian Tertiary Care Center

MM - 479

Diagnostic and Therapeutic Access Gaps in Newly Diagnosed Multiple Myeloma: Real-World Evidence From a North Indian Tertiary Care Center

Abhishek Yadav

Poster Presenter: Abhishek Yadav

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia (ET)

MPN - 481

Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia (ET)

Haris Ali

Poster Presenter: Haris Ali

$Thumbnail for Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) Versus Rituximab Plus GemOx (R-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the 3-Year Follow-Up of STARGLO$

ABCL - 483

Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) Versus Rituximab Plus GemOx (R-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the 3-Year Follow-Up of STARGLO

Haifaa Abdulhaq

Poster Presenter: Haifaa Abdulhaq

$Thumbnail for A Real-World Study of the Effectiveness and Safety of Post-Tafasitamab Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)$

ABCL - 484

A Real-World Study of the Effectiveness and Safety of Post-Tafasitamab Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Kim Saverno

Poster Presenter: Kim Saverno

Thumbnail for Deconvolution of Peripheral Blood Transcriptomes to Evaluate Immune Profiles Associated With Measurable Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Machine Learning-Driven Study

ALL - 486

Deconvolution of Peripheral Blood Transcriptomes to Evaluate Immune Profiles Associated With Measurable Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Machine Learning-Driven Study

Fatima Aslam

Poster Presenter: Fatima Aslam

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors